Precision medicine trial for Parkinson's and Alzheimer's
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial uses advanced tools to better diagnose and treat Parkinson's disease and Alzheimer's disease. It aims to personalize care based on your specific symptoms and biomarkers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease with at least two of these: tremor, stiffness, slow movement, or symptoms starting on one side, and one of them must be tremor or slow movement.
- You do not have unusual symptoms like early falls, confusion, hallucinations, or vision problems.
- Your Parkinson's symptoms have improved with levodopa or similar medications, or you haven't had a proper trial of these drugs.
- You have Alzheimer's disease confirmed by a positive amyloid PET scan or spinal fluid test.
- You do not have other brain diseases like multiple sclerosis, ALS, or epilepsy.
- You do not have a diagnosis of dementia (for Alzheimer's patients) or pre-existing psychiatric disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This study looks for “autoimmune-like” (immune-system) features in brain-related diseases such as Parkinson’s and Alzheimer’s, using genetic testing and other assessments. Results may help researchers understand what drives these conditions and who might be more likely to have immune-related changes.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.